In the genus Campylobacter there are 15 species, three of which are signifi
cant human pathogens. The organism is a uniquely small, Gram-negative rod f
ound primarily in zoonotic reservoirs from which humans can be infected. Di
fferent clinical features ranging from watery diarrhoea to dysentery and su
bsequent possible sequelae result from infection. Several immunodominant an
tigens are now recognized and these have been exploited for use in epidemio
logical typing methods and are gradually being analyzed to determine their
role in pathogenesis. Although the nature of Campylobacter pathogenesis rem
ains elusive, some information is now available on adherence, invasion and
toxicity. Fortunately, clinical laboratory diagnosis is now routine and num
erous molecular characterization procedures are potentially available. Vacc
ine development is underway, but thus far, significant protection has not b
een demonstrated. Fluoroquinolones remain the drugs of choice for severe ga
stroenteritis, although resistance to these antibiotics and to the macrolid
es, is beginning to emerge. (C) 2001 Lippincott Williams & Wilkins.